The shares of McEwen Mining Inc. have increased by more than 3.95% this year alone. The shares recently went up by 8.22% or $0.18 and now trades at $2.37. The shares of CorMedix, Inc. (NYSE:CRMD), has jumped by 11.53% year to date as of 02/14/2018. The shares currently trade at $0.56 and have been able to report a change of 20.07% over the past one week.
The stock of McEwen Mining Inc. and CorMedix, Inc. were two of the most active stocks on Wednesday. Investors seem to be very interested in what happens to the stocks of these two companies but do investors favor one over the other? We will analyze the growth, profitability, risk, valuation, and insider trends of both companies and see which one investors prefer.
Profitability and Returns
Growth alone cannot be used to see if the company will be valuable. Shareholders will be the losers if a company invest in ventures that aren’t profitable enough to support upbeat growth. In order for us to accurately measure profitability and return, we will be using the EBITDA margin and Return on Investment (ROI), which balances the difference in capital structure. These figures suggest that MUX ventures generate a higher ROI than that of CRMD.
The value of a stock is ultimately determined by the amount of cash flow that the investors have available. Over the last 12 months, MUX’s free cash flow per share is a positive 0, while that of CRMD is negative -3.35.
Liquidity and Financial Risk
The ability of a company to meet up with its short-term obligations and be able to clear its longer-term debts is measured using Liquidity and leverage ratios. The current ratio for MUX is 4.20 and that of CRMD is 3.30. This implies that it is easier for MUX to cover its immediate obligations over the next 12 months than CRMD. The debt ratio of MUX is 0.00 compared to 0.00 for CRMD. CRMD can be able to settle its long-term debts and thus is a lower financial risk than MUX.
MUX currently trades at a forward P/E of 103.04, a P/B of 1.45, and a P/S of 14.91 while CRMD trades at a P/B of 3.50, and a P/S of 97.32. This means that looking at the earnings, book values and sales basis, MUX is the cheaper one. It is very obvious that earnings are the most important factors to investors, thus analysts are most likely to place their bet on the P/E.
Analyst Price Targets and Opinions
The mistake some people make is that they think a cheap stock has more value to it. In order to know the value of a stock, there is need to compare its current price to its likely trading price in the future. The price of MUX is currently at a -37.63% to its one-year price target of 3.80. Looking at its rival pricing, CRMD is at a -86% relative to its price target of 4.00. This figure implies that over the next one year, CRMD is a better investment.
When looking at the investment recommendation on say a scale of 1 to 5 (1 being a strong buy, 3 a hold, and 5 a sell), MUX is given a 2.00 while 2.00 placed for CRMD. This means that analysts are equally bullish on their outlook for the two stocks stocks.
Insider Activity and Investor Sentiment
Short interest or otherwise called the percentage of a stock’s tradable shares currently being shorted is another data that investors use to get a handle on sentiment. The short ratio for MUX is 14.91 while that of CRMD is just 4.71. This means that analysts are more bullish on the forecast for CRMD stock.
The stock of CorMedix, Inc. defeats that of McEwen Mining Inc. when the two are compared, with CRMD taking 4 out of the total factors that were been considered. CRMD happens to be more profitable, generates a higher ROI, has higher cash flow per share, higher liquidity and has a lower financial risk. When looking at the stock valuation, CRMD is the cheaper one on an earnings, book value and sales basis. Finally, the sentiment signal for CRMD is better on when it is viewed on short interest.